Looks like you clickedhttps://www.globenewswire.com/en/news-release/2022/06/16/2464341/0/en/LAVA-Therapeutics-Highlights-Encouraging-Clinical-Updates-on-Lead-Program-LAVA-051-in-Chronic-Lymphocytic-Leukemia-and-Multiple-Myeloma-Patients.html
If you do not want to visit that page, you can close this browser tab.
